Kinfo
BG

Bionexus Gene Lab Corp.

BGLCNASDAQ·US · USD
$2.07
+0.03 (+1.47%)
Close · 2026-06-26

Price

Key statistics

Valuation
Market cap5.00M USD
Enterprise value1.39M USD
Trailing P/E-1.29
Forward P/E0.00
PEG ratio0.04
Price / sales0.94
Price / book0.62
Profitability
Gross margin-3.46%
Operating margin-2466.01%
Profit margin-54.70%
Return on assets-20.76%
Return on equity-36.62%
Income (TTM)
Revenue5.31M USD
Gross profit740.93K USD
EBITDA-2.96M USD
Net income-2.90M USD
Diluted EPS-$1.49
Rev. growth (YoY)-98.90%
Balance sheet
Total cash3.96M USD
Total debt346.62K USD
Debt / equity4.28
Current ratio6.52
Book value / share$3.35
Cash flow (TTM)
Operating cash flow-1.16M USD
Levered free cash flow-170.05K USD
Shares & price
Shares outstanding2.42M
Float1.76M
Held by institutions0.01%
Beta2.19
50-day MA$2.18
200-day MA$3.41
52-week high$15.60
52-week low$1.07
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-02-121.031.07+3.88%

Frequently asked questions about Bionexus Gene Lab Corp.